Valuation: HitGen Inc.

Market Cap 13.42B 2.01B 1.81B 1.67B 1.51B 2.83B 191B 2.86B 19.99B 7.94B 100B 7.55B 7.39B 318B P/E 2026 *
90.5x
P/E 2027 * 69.1x
Enterprise Value 13.42B 2.01B 1.81B 1.67B 1.51B 2.83B 191B 2.86B 19.99B 7.94B 100B 7.55B 7.39B 318B EV / Sales 2026 *
19.5x
EV / Sales 2027 * 15.7x
Free-Float
51.86%
Yield 2026 *
0.35%
Yield 2027 * 0.58%
1 day-5.07%
1 week-11.12%
Current month-25.06%
1 month-24.21%
3 months+12.91%
6 months+25.90%
Current year+42.81%
1 week 33.35
Extreme 33.35
37.99
1 month 33.35
Extreme 33.35
46.22
Current year 22.42
Extreme 22.42
47.58
1 year 21.46
Extreme 21.46
47.58
3 years 8.35
Extreme 8.35
47.58
5 years 8.35
Extreme 8.35
47.58
10 years 8.35
Extreme 8.35
61.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2012
Director of Finance/CFO 56 27/04/2023
Investor Relations Contact 38 01/07/2019
Director TitleAgeSince
Chairman 63 01/06/2012
Director/Board Member 73 01/02/2012
Director/Board Member 65 24/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 A Buy

Chief Financial Officer

17,500 0.0044%
9/22/26 A Buy

Executive/Senior Manager

25,000 0.0062%
9/22/26 A Buy

Chief Executive Officer

94,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-5.07%-11.12%+43.36%+131.76% 2.12B
-3.10%-4.19%+32.67%+59.47% 65.28B
+0.33%+0.33%+10.16%+78.07% 54.57B
+0.16%+1.73%+9.89%+102.10% 53.59B
-0.75%+1.38%+24.89%+50.91% 45.03B
-1.30%-4.80%+16.05%+114.76% 42.17B
+1.26%-5.26%+221.12%+900.64% 39.42B
-0.74%-4.46%+11.00%+44.65% 32.71B
+1.11%+15.18%+60.27%+49.33% 26.5B
+1.66%-8.06%+23.56%-10.06% 24.01B
Average -0.64%-1.14%+45.30%+152.16% 38.54B
Weighted average by Cap. -0.47%-0.64%+42.41%+153.22%

Financials

2026 *2027 *
Net sales 687M 103M 92.41M 85.32M 77.37M 145M 9.78B 146M 1.02B 406M 5.13B 386M 378M 16.26B 853M 128M 115M 106M 96.16M 180M 12.15B 182M 1.27B 505M 6.37B 480M 470M 20.2B
Net income 149M 22.29M 20.01M 18.47M 16.75M 31.31M 2.12B 31.7M 221M 87.97M 1.11B 83.68M 81.89M 3.52B 194M 29.11M 26.13M 24.12M 21.87M 40.88M 2.76B 41.39M 289M 115M 1.45B 109M 107M 4.6B
Net Debt - -
Projected Income Statement - Annual - HitGen Inc.
Logo HitGen Inc.
HitGen Inc is a China-based company primarily engaged in the research, development and optimization of small molecule and nucleic acid-based new drug candidates using deoxyribonucleic acid (DNA) encoded chemical library (DEL) technology. Through the drug discovery and optimization platform, the Company provides clients with services such as screening and optimization of designated biological targets, customized DEL design and synthesis, synthesis and modification of certain designated compounds or nucleic acids and related biological evaluation. The Company is also engaged in the transfer of rights and interests in new drug research projects, capital operations and marketing activities. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States, France, the United Kingdom and Japan.
Employees
706
Date Price Change Volume
27/10/26 CN¥33.49 -5.07% 17,234,205
26/10/26 CN¥35.28 -4.85% 19,793,787
23/10/26 CN¥37.08 +5.34% 24,706,587
22/10/26 CN¥35.20 -5.22% 23,572,449
21/10/26 CN¥37.14 -1.43% 23,514,616
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - HitGen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
33.49CNY
Average target price
43.60CNY
Spread / Average Target
+30.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - HitGen Inc.
  1. Stock Market
  2. Stocks
  3. 688222 Stock